Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse,Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology

American Psychiatric Association (1994) Diagnostic and Statistics Manual for Mental disorders (DSM-IV). American Psychiatric Association, Washington, DC

Addington J , el- Guebaly N , Campbell W , Hodgins D , Addington D (1998) Smoking cessation treatment for patients with schizophrenia . Am J Psychiatry 155: 974–978

Addis A , Moretti M E , Ahmed S F , Einarson T R , Koren G (2001) Fetal effects of cocaine: an updated meta-analysis . Reprod Toxicol 15: 341–369

Albanese M J , Khantzian E J , Murphy S L , Green A I (1994) Decreased substance use in chronically psychotic patients treated with clozapine . Am J Psychiatry 151: 780–781

Alldredge B K , Lowenstein D H , Simon R P (1989) Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures . Am J Med 87: 645–648

Amato L , Davoli M , Ferri M , Ali R (2003) Methadone at tapered doses for the management of opioid withdrawal (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Amato L , Davoli M , Ferri M , Gowing L , Perruci C (2004) Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews . Drug Alcohol Depend 73: 219–226

Anderson I M , Nutt D J , Deakin J F (2000) Evidence-based guidelinesfor treating depressive disorders with antidepressants: a revision ofthe 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology . J Psychopharmacol 14: 3–20

Anglin M D (1988) The efficacy of civil commitment in treating narcotic addiction . NIDA Res Monogr 86: 8–34

Anton R F , Moak D H , Waid L R , Latham P K , Malcolm R J , Dias J K (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial . Am J Psychiatry 156: 1758–1764

Anton R , Moak D , Latham P , Randolph W , Malcolm R , Dias J , Roberts J (2001) Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism . J Consult Clin Psychopharm 21: 72–77

Archie C (1998) Methadone in the management of narcotic addiction in pregnancy . Curr Opin Obstet Gynecol 10: 435–440

Arndt I , Dorozynsky L , Woody G , McLellan A , O’Brien C (1992) Desipramine treatment of cocaine dependence in methadone-maintained patients . Arch Gen Psychiatry 49: 888–893

Ashton C , Rawlins M , Tyrer S (1990) A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users . Br J Psychiatry 157: 232–238

Ashton H (1987) Benzodiazepine withdrawal: outcome in 50 patients . Br J Addict 82: 665–671

Auriacombe M , Franques P , Tignol J (2001) Deaths attributable to methadone versus buprenorphine in France . JAMA 285: 45-45

Balldin J , Berggren U , Engel J , Eriksson E , Hard E , Soderpalm B (1994) Effect of citalopram on alcohol intake in heavy drinkers . Alcohol Clin Exp Res 18: 1133–1136

Ballenger J C , Post R M (1978) Kindling as a model for alcohol withdrawal syndromes . Br J Psychiatry 133: 1–14

Banjeree S , Clancy C , Crome I (2001) Co-existing problems of mental disorder and substance misuse (dual diagnosis). An information Manual. Final Report to the Department of Health. Royal College of Psychiatrists’ Research Unit, London

Bashir K , King M , Ashworth M (1994) Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines . Br J Gen Pract 44: 408–412

Batki S L , Manfredi L B , Sorensen J L , Jacob P , Dumontet R , Jones R T (1991) Fluoxetine for cocaine abuse in methadone patients: preliminary findings . NIDA Res Monogr 105: 516–517

Batki S L , Washburn A M , Delucchi K , Jones R T (1996) A controlled trial of fluoxetine in crack cocaine dependence . Drug Alcohol Depend 41: 137–142

Bavon A (2001) The effect of the Tarrant County drug court project on recidivism . Eval Program Plan 24: 13–22

Berglund M , Thelander S , Jonsson E (2003) Treating alcohol and drug abuse. An evidence based review. WILEY-VCH Verlag GmbH and Co., KGaA Weinheim

Besson J , Aeby F , Kasas A , Lehert P , Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study . Alcohol Clin Exp Res 22: 573–579

Best D , Noble A , Man L , Gossop M , Finch E , Strang J (2002) Factors surrounding long-term benzodiazepine prescribing in methadone maintenance clients . J Subst Abuse Treat 7: 175–179

Bien T H , Miller W R , Tonigan J S (1993) Brief interventions for alcohol problems: a review . Addiction 88: 315–335

Blondal T , Gudmundsson L , Tomasson K , Jonsdottir D , Hilmarsdottir H , Kristjansson F , Nilsson F , Bjornsdottir U (1999) The effects of fluoxetine combined with nicotine inhalers in smoking cessation – a randomized trial . Addiction 94: 1007–1015

Bobo J , McIlvain H , Lando H , Dale Walker R, Leed-Kelly A (1998) Effect of smoking cessation counselling on recovery from alcoholism: findings from a randomized community intervention trial . Addiction 93: 877–887

Brooke D , Edwards G , Andrews T (1993) Doctors and substance misuse: types of doctors, types of problems . Addiction 88: 655–663

Brown E S , Nejtek V A , Perantie D C , Bobadilla L (2002) Quetiapine in bipolar disorder and cocaine dependence . Bipolar Disord 4: 406–411

Brown E S , Nejtek V A , Perantie D C , Orsulak P J , Bobadilla L (2003) Lamotrigine in patients with bipolar disorder and cocaine dependence . J Clin Psychiatry 64: 197–201

Brown R , Kahler C , Niaura R , Abrams D , Sales S , Ramsey S , Goldstein M , Burgess E , Miller I (2001) Cognitive-behavioral treatment for depression in smoking cessation . J Consult Clin Psychol 69: 471–480

Brown S A , Irwin M , Schuckit M A (1991) Changes in anxiety among abstinent male alcoholics . J Stud Alcohol 52: 55–61

Buckley P (1998a) Substance abuse in schizophrenia: a review . J Clin Psychiatry 59: 26–30

Buckley P (1998b) Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia . J Subst Abuse Treat 15: 113–116

Buckley P , Thompson PA , Way L , Meltzer H Y (1994a) Substance abuse and clozapine treatment . J Clin Psychiatry 55 (Suppl B): 114–116

Buckley P , Thompson P , Way L , Meltzer H Y (1994b) Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy . Am J Psychiatry 151: 385–389

Burling T , Burling A , Latini D (2001) A controlled smoking cessation trial for substance-dependent inpatients . J Consult Clin Psychol 69: 295–304

Campbell B K , Wander N , Stark M J , Holbert T (1995) Treating cigarette smoking in drug-abusing clients . J Subst Abuse Treat 12: 89–94

Campbell B K , Krumenacker J , Stark M J (1998) Smoking cessation for clients in chemical dependence treatment. A demonstration project . J Subst Abuse Treat 15: 313–318

Cantwell R , Brewin J , Glazebrook C , Dalkin T , Fox R , Medley I , Harrison G (1999) Prevalence of substance misuse in first-episode psychosis . Br J Psychiatry 174: 150–153

Carpenter K , Brooks A , Vosburg S , Nunes E (2004) The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial . Drug Alcohol Depend 74: 123–134

Carroll K M , Rounsaville B J , Gordon L T , Nich C , Jatlow P , Bisichini R , Gawin F (1994a) Psychotherapy and pharmacotherapy for ambulatory cocaine abusers . Arch Gen Psychiatry 51: 177–187

Carroll K M , Rounsaville B J , Nich C , Gordon L T , Wirtz P W , Gawin F (1994b) One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects . Arch Gen Psychiatry 51: 989–997

Carroll K M , Nich C , Rounsaville B J (1995) Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy . J Nerv Ment Dis 183: 251–259

Carroll K M , Nich C , Ball S A , McCance E , Rounsavile B J (1998) Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram . Addiction 93: 713–727

Carroll K M , Nich C , Ball S A , McCance E , Frankforter T L , Rounsaville B J (2000) One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment . Addiction 95: 1335–1349

Carroll K M , Fenton L R , Ball S A , Nich C , Frankforter T L , Shi J , Rounsaville B J (2004a) Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial . Arch Gen Psychiatry 61: 264–272

Carroll K , Nich C , Rounsaville B (2004b) Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy . J Nerv Ment Dis 183: 251–259

Chance J F (1991) Emergency department treatment of alcohol withdrawal seizures with phenytoin . Ann Emerg Med 20: 520–522

Chang G , Wilkins-Haug L , Berman S , Goetz M A (1999) Brief intervention for alcohol use in pregnancy: a randomized trial . Addiction 94: 1499–1508

Charney D , Paraherakis A , Gill K (2000) The treatment of sedative-hypnotic dependence: evaluating clinical predictors or outcome . J Clin Psychiatry 61: 190–195

Chick J , Gough K , Falkowski W , Kershaw P , Hore B , Mehta B , Ritson B , Ropner R , Torley D (1992) Disulfiram treatment of alcoholism . Br J Psychiatry 161: 84–89

Chick J , Howlett H , Morgan M , Ritson B (2000a) United Kingdom multicentre acamprosate study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol . Alcohol Alcohol 35: 176–187

Chick J , Anton R , Chechinski K , Croop R , Drummond D , Farmer R , Labriola D , Marshall J , Moncrieff J , Morgan M , Peters T , Ritson B (2000b) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse . Alcohol Alcohol 35: 587–593

Chick J , Lehert P , Landron F (2003) Does acamprosate improve reduction of drinking as well as aiding abstinence? J Psychopharmacol 17: 397–402

Chick J , Aschauer H , Hornik K (2004) Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year double-blind placebo-controlled multicentre study with analysis by typology . Drug Alcohol Depend 74: 61–70

Ciraulo D A , Jaffe J H (1981) Tricyclic antidepressants in the treatment of depression associated with alcoholism . J Clin Psychopharmacol 1: 146–150

Ciraulo D A , Nace E P (2000) Benzodiazepine treatment of anxiety or insomnia in substance abuse patients . Am J Addict 9: 276–279

Ciraulo D A , Barnhill J G , Ciraulo A M , Sarid-Segal O , Knapp C , Greenblatt D J , Shader R I (1997) Alterations in pharmacodynamicsof anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone . J Clin Pharmacol 37: 64–73

Ciraulo D , Sands B , Shader R (1988) Critical review of liability for benzodiazepine abuse among alcoholics . Am J Psychiatry 145: 1501–1506

Comer S , Collins E , Kleber H , Nuwayser E , Kerrigan J , Fischman M (2002) Depot naltrexone: long-lasting antagonism of the effects of heroin in humans . Psychopharmacology 159: 351–360

Condelli W S , Fairbank J A , Dennis M L , Rachal J V (1991) Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions . J Subst Abuse Treat 8: 203–212

Conley R , Kelly D , Gale E (1998) Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse . Biol Psychiatry 33: 95–101

Cook C C , Hallwood P M , Thomson A D (1998) B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse . Alcohol Alcohol 33: 317–336

Cormack M , Woens R , Dewey M (1989) The effect of minimal interventions by general practitioners on long-term benzodiazepines use . J Royal Coll Gen Pract 39: 408–411

Cornelius J , Salloum I , Ehler J , Jarrett P , Cornelius M , Perel J , Thase M , Black A (1997) Fluoxetine in depressed alcoholics . Arch Gen Psychiatry 54: 700–705

Cornelius J , Salloum I , Thase M , Haskett R , Daley D , Jones-Barlock A , Upsher C , Perel J (1998) Fluoxetine versus placebo in depressed alcoholic cocaine abusers . Psychopharmacol Bull 34: 117–121

Cornelius J , Salloum I , Haskett R , Daley D , Cornelius M , Thase M , Perel (2000) Fluoxetine versus placebo in depressed alcoholics: a 1-yearfollow-up study . Addict Behav 25: 307–310

Couvee J , Oude-Voshaar R , van Balkom A , Zitman F (2003) Strategies to discontinue long term benzodiazepine use: a systematic review. In Couvee J (ed), Towards a treatment of chronic benzodiazepine users suffering from depression. Glaxo SmithKline BV, The Netherlands ,

Covi L , Hess J , Kreiter N , Haertzen C (1995) Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers . Am J Drug Alcohol Abuse 21: 327–344

Crawford V (2001) Co-existing problems of mental disorder and substance misuse (dual diagnosis): a review of relevant literature. Final report to the Department of Health. Royal College of Psychiatrists’ Research Unit, London

Crits-Christoph P , Siqueland L , Blaine J , Frank A , Luborsky L , Onken L S , Muenz L R , Thase M E , Weiss R D , Gastfriend D R , Woody G E , Barber J P , Butler S F , Daley D , Salloum I , Bishop S , Najavits L M , Lis J , Mercer D , Griffin M L , Moras K , Beck A T (1999) Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study . Arch Gen Psychiatry 56: 493–502

Crome I B (1997) Alcohol problems in the older person . J Roy Soc Med 90 (Suppl 32): 16–22

Crome I B , Day E (1999) Substance misuse and dependence: Older people deserve better services . Rev Clin Gerontol 9: 327–342

Crome I B , McCardle P , Gilvarry E , Bailey S (2004) Treatment. In Crome I , Ghodse H , Gilvarry E , McCardle P (eds), Young people and substance misuse, pp. 140–162. Gaskell, London

D’Onofrio G , Rathlev N K , Ulrich A S , Fish S S , Freedland E S (1999) Lorazepam for the prevention of recurrent seizures related to alcohol . N Engl J Med 340: 915–919

Daeppen J-B , Gache P , Landry U , Sekera E , Schweizer V , Gloor S , Yersin B (2002) Symptom-triggered versus fixed-schedule doses of benzodiazepine for alcohol withdrawal . Arch Intern Med 162: 1117–1121

Department of Health , The Scottish Office , The Welsh Office and DHSS Northern Ireland (1999) Drug Misuse and Dependence: Guidelines on Clinical Management. [available at www.doh.gov.uk]

Desland M L , Batey R G (1992) A 12-month prospective comparison of court-diverted with self-referred heroin users . Drug Alcohol Rev 11: 121–129

Desmond D P , Maddux J F (1996) Compulsory supervision and methadone maintenance . J Subst Abuse Treat 13: 79–83

Drake R E , Xie H , McHugo G J , Green A I (2000) The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia . Schizophr Bull 26: 441–449

Drake R , Essock S , Shaner A , Carey K , Minkoff K , Kola L , Lynde D , Osher F , Rickards L (2001) Implementing dual diagnosis services for clients with severe mental illness . Psychiatr Serv 52: 469–476

Drozdick J III , Berghella V , Hill M , Kaltenbach K (2002) Methadone trough levels in pregnancy . Am J Obstet Gynecol 187: 1184–1188

Drummond D C , Turkington D , Rahman M Z , Mullin P J , Jackson P (1989) Chlordiazepoxide versus methadone in opiate withdrawal: a preliminary double blind trial . Drug Alcohol Depend 23: 63–71

Duka T , Townshend J M , Collier K , Stephens D N (2003) Impairment in cognitive functions after multiple detoxifications in alcoholic inpatients . Alcohol Clin Exp Res 27(10): 1563–1572

Duncan D , Taylor D (1996) Chlormethiazole or chlordiazepoxide in alcohol detoxification . Psychiatr Bull 20: 599–601

Dunn C , Deroo L , Rivara F (2001) The use of brief interventions adapted from motivational interviewing across behavioural domains: a systematic review . Addiction 96: 1725–1742

Dunner D , Zisook S , Billow A , Batey S , Johnston J , Ascher J (1998) A prospective safety surveillance study for bupropion sustained-release in the treatment of depression . J Clin Psychiatry 59: 366–373

Edwards G , Gross M (1976) Alcohol dependence: provisional description of a clinical syndrome . BMJ 1: 1058–1061

El Guebaly N , Cathcart J , Currie S , Brown D , Gloster S (2002a) Public health and therapeutic aspects of smoking bans in mental health and addiction settings . Psychiatr Serv 53: 1617–1622

El Guebaly N , Cathcart J , Currie S , Brown D , Gloster S (2002b) Smoking cessation approaches for persons with mental illness or addictive disorders . Psychiatr Serv 53: 1166–1170

Elsesser K , Sartory G , Maurer J (1996) The efficacy of complaints management training in facilitating benzodiazepine withdrawal . Behav Res Ther 34: 149–156

Evins A , Mays V , Rigotti N , Tisdale T , Cather C , Goff D (2001) A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia . Nicotine Tob Res 3: 397–403

Faggiano F , Vigna-Taglianti F , Versino E , Lemma P (2003) Methadone maintenance at different dosages for opioid dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Farrell M , Ward J , Mattick R , Hall W , Stimson GV , des JD , Gossop M , Strang J (1994) Methadone maintenance treatment in opiate dependence: a review . BMJ 309: 997–1001

Farrell M , Howes S , Bebbington P , Brugha T , Jenkins R , Lewis G , Marsden J , Taylor C , Meltzer H (2001) Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey . Br J Psychiatry 179: 432–437

Fawcett J , Kravitz H , McGuire M , Easton M , Ross J , Pisani V , Fogg L , Clark D , Whitney M , Kravitz G , Javaid J , Teas G (2000) Pharmacological treatment for alcoholism: revisiting lithium and considering buspirone . Alcohol Clin Exp Res 24: 666–674

Feeney G , Young R , Connor J , Tucker J , McPherson A (2002) Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved? Austr NZ J Psychiatry 36: 622–628

Ferri M , Davoli M , Perruci C (2004) Heroin maintenance for chronic heroin dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Fleming PM , Roberts D (1994) Is the prescription of amphetamine justified as a harm reduction measure? J Royal Soc Health 114: 127–131

Foster J , Brewer C , Steele T (2003) Naltrexone implants can completely prevent early (1 month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels . Addiction Biol 8: 211–217

Freemantle N , Gill P , Godfrey C , Long A , Richards C , Sheldon TA , Song F , Webb J (1993) Brief interventions and alcohol use . Qual Health Care 2: 267–273

Fryer J , Lukas R (1999) Noncompetitive functional inhibition at diverse, human acetylcholine receptor subtypes by bupropion . J Pharmacol Exp Ther 288: 88–92

Fugelstad A , Agren G , Romelsjo A (1998) Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment . Subst Use Misuse 33: 2803–2817

Fuller R K , Roth H P (1979) Disulfiram for the treatment of alcoholism. An evaluation in 128 men . Ann Intern Med 90: 901–904

Fulwiler R L , Hargreaves W A , Bortman R A (1979) Detoxification from heroin using self versus physician regulation of methadone dose . Int J Addict 14: 289–298

Garbutt J C , West S L , Carey T S , Lohr K N , Crews F T (1999) Pharmacological treatment of alcohol dependence: a review of the evidence . JAMA 281: 1318–1325

Garfinkel D , Zisapel N , Wainstein J , Laudon M (1999) Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach . Arch Intern Med 159: 2456–2460

Gastpar M , Bonnet U , Boning J , Mann K , Schmidt L , Soyka M , Wetterling T , Kielstein V , Labriola D , Croop R (2002) Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study . J Clin Psychopharmacol 22: 592–598

Gawin F H , Kleber H D , Byck R , Rounsaville B J , Kosten T R , Jatlow P I , Morgan C (1989) Desipramine facilitation of initial cocaine abstinence . Arch Gen Psychiatry 46: 117–121

George T P , Chawarski M C , Pakes J , Carroll K M , Kosten T R , Schottenfeld R S (2000a) Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial . Biol Psychiatry 47: 1080–1086

George T P , Ziedonis D M , Feingold A , Pepper W T , Satterburg C A , Winkel J , Rounsaville B J , Kosten T R (2000b) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia . Am J Psychiatry 157: 1835–1842

George T P , Sernyak M J , Ziedonis D M , Woods S W (1995) Effects of clozapine on smoking in chronic schizophrenic outpatients . J Clin Psychiatry 56(8): 344–346

George T P , Vessicchio J C , Termine A , Bregartner T A , Feingold A , Rounsaville B J , Kosten T R (2002) A placebo controlled trial of bupropion for smoking cessation in schizophrenia . Biol Psychiatry 52: 53–61

Gerra G , Caccavari R , Delsignore R , Bocchi R , Fertonani G , Passeri M (1992) Effects of fluoxetine and Ca-acetly homotaurinate on alcohol intake in familial and nonfamilial alcohol patients . Curr Ther Res 52: 291–295

Goodwin G M (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology . J Psychopharmacol 17: 149–173

Gossop M , Marsden J , Stewart D , Lehmann P , Strang J (1999) Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study . Br J Gen Pract 49: 31–34

Gowing L , Ali R , White J (2003a) Buprenorphine for the management of opioid withdrawal (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd. Chichester

Gowing L , Farrell M , Ali R , White J (2003b) Alpha2 adrenergic agonists for the management of opioid withdrawal (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Gowing L , Farrell M , Bornemann R , Ali R (2004) Substitution treatment of injecting opioid users for preventing transmission of HIV infection (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester (in press)

Grabowski J , Rhoades H , Elk R , Schmitz J , Davis C , Creson D , Kirby K (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlleddouble-blind trials . J Consult Clin Psychopharmacol 15: 163–174

Green A , Salomon M , Brenner M , Rawlins K (2002) Treatment of schizophrenia and comorbid substance use disorder . Curr Drug Targets – CNS Neurol Disord 1: 129–139

Green A , Burgess E , Dawson R , Zimmet S , Strous R (2003) Alcohol and cannabis use in schizophrenia: effects of clozapine versus risperidone . Schizophr Res 60: 81–85

Green A , Tohen M , Hamer R , Strakowski S , Lieberman J , Glick I , Clark W , HGDH Research Group (2004) First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol . Schizophr Res 00: 125–135

Green L , Gossop M (1988) Effects of information on the opiate withdrawal syndrome . Br J Addict 83: 305–309

Greenwood J (1996) Six years’ experience of sharing the care of Edinburgh’s drug users . Psychiatr Bull 20: 8–11

Gual A , Lehert P (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain . Alcohol Alcohol 36: 413–418

Habraken H , Soenen K , Blondeel L , Van Elsen J , Bourda J , Coppens E , Willeput M (1997) Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research . Eur J Clin Pharmacol 51: 355–358

Hall S M , Bass A , Hargreaves W A , Loeb P (1979) Contingency management and information feedback in outpatient heroin detoxification . Behav Ther 10: 443–451 .

Hall S , Munoz R , Reus V (1994) Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers . J Consult Clin Psychol 62: 141–146

Hall S , Munoz R , Reus V , Sees K , Duncan C , Humfleet G , Hartz D (1996) Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study . J Consult Clin Psychol 64: 1003–1009

Hall S , Reus V , Munoz R , Sees K , Humfleet G , Hartz D , Frederick S , Triffleman E (1998) Nortiptyline and cognitive-behavioral therapy in the treatment of cigarette smoking . Arch Gen Psychiatry 55: 683–690

Haller D , Knisely J , Elswick R , Dawson K , Schnoll S (1997) Perinatal substance abusers; factors influencing treatment retention , J Subst Abuse Treatment 14(6): 513–519

Handmaker N S , Miller W R , Manicke M (1999) Findings of a pilot study of motivational interviewing with pregnant drinkers . J Stud Alcohol 60: 285–287

Hankin J , McCaul ME , Heussner J (2000) Pregnant, alcohol-abusing women . Alcohol Clin Exp Res 24: 1276–1286

Harrison M , Busto U , Naranjo C , Kaplan H , Sellers E (1984) Diazepam tapering in detoxification for high dose benzodiazepine abuse . Clin Pharmacol Ther 36: 527–533

Hartnoll R , Mitcheson M , Battersby A , Brown G , Ellis M , Fleming P , Hedley N (1980) Evaluation of heroin maintenance in controlled trial . Arch Gen Psychiatry 37: 877–884

Hayford K , Patten C , Rummans T , Schroeder D , Offord K , Croghan I , Glover E , Sachs D , Hurt R (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism . Br J Psychiatry 174: 173–178

Hays J , Schroeder D , Offord K , Croghan I , Patten C , Hurt R , Jorenby D , Fiore M (1999) Response to nicotine dependence treatment in smokers with current and past alcohol problems . Ann Behav Med 21: 244–250

Heale P , Lang E (2001) A process evaluation of the CREDIT (Court Referral and Evaluation for Drug Intervention and Treatment) pilot programme . Drug Alcohol Rev 20: 223–230

Health Advisory Service (2001) Substance misuse and mental health comorbidity (dual diagnosis). Standards for Mental Health Services. Health Advisory Service, London , available from www.nta.nhs.uk

Healy D , Nutt D J (1998) Prescriptions, licenses and evidence . Psychiatr Bull 22: 680–684

Heinala P , Alho H , Kiianmaa K , Lonnqvist J , Kuoppasalmi K , Sinclair J (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial . J Clin Psychopharmacol 21: 287–292

Hersh D , Van Kirk J , Kranzler H (1998) Naltrexone treatment of comorbid alcohol and cocaine use disorders . Psychopharmacology 139: 44–52

Higgins S T , Sigmon S C , Wong C J , Heil S H , Badger G J , Donham R , Dantona R L , Anthony S (2003) Community reinforcement therapy for cocaine-dependent outpatients . Arch Gen Psychiatry 60: 1043–1052

Hillbom M , Pieninkeroinen I , Leone M (2003) Seizures in alcohol-dependent patients . CNS Drugs 17: 1013–1030

Holbrook A M , Crowther R , Lotter A , Cheng C , King D (1999) Metaanalysis of benzodiazepine use in the treatment of acute alcohol withdrawal . CMAJ 160: 649–655

Holder H , Longabaugh R , Miller W R , Rubinois A V (1991) The cost effectiveness of treatment for alcoholism: a first approximation . J Stud Alcohol 52: 517–540

Holton A , Tyrer P (1990) Five year outcome in patients withdrawn from long term treatment with diazepam . BMJ 300: 1241–1242

Hser Y I , Anglin D , Powers K (1993) A 24-year follow-up of California narcotics addicts . Arch Gen Psychiatry 50: 577–584

Hughes J , Cook C (1997) The efficacy of disulfiram: a review of outcome studies . Addiction 92: 381–395

Hughes J R , Novy P , Hatsukami D K , Jensen J , Callas P W (2003) Efficacy of nicotine patch in smokers with a history of alcoholism . Alcohol Clin Exp Res 27: 946–954

Hughes J , Stead L , Lancaster T (2004) Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Hurt R , Patten C (2003) Treatment of tobacco dependence in alcoholics . Recent Dev Alcohol 16: 335–359

Hurt R D , Eberman K M , Croghan I T , Offord K P , Davis L J Jr , Morse R M , Palmen M A , Bruce B K (1994) Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial . Alcohol Clin Exp Res 18: 867–872

Iga J I , Araki M , Ishimoto Y , Ohmori T (2001) A case of Korsakoff’s syndrome improved by high doses of donepezil . Alcohol Alcohol 36: 553–555

Jaffe A J , Rounsaville B , Chang G , Schottenfeld R S , Meyer R E , O’Malley S S (1996) Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching . J Consult Clin Psychol 64: 1044–1053

Jansson L M , Svikis D , Lee J , Paluzzi P , Rutigliano P , Hackerman F (1996) Pregnancy and addiction. A comprehensive care model . J Subst Abuse Treat 13: 321–329

Johnson B A , Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: scientific basis and clinical findings . Psychopharmacology (Berl) 149: 327–344

Johnson B A , Aid-Daoud N , Bowden C , DiClemente C , Roache J , Lawson K , Javors M , Ma J (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial . Lancet 361: 1677–1685

Johnson E , Breslau N , Anthony J (1996) The latent dimensionality of DIS/DSM-III-R nicotine dependency: exploratory analyses . Addiction 91: 583–588

Johnson R E , Jones H E , Fischer G (2003) Use of buprenorphine in pregnancy: patient management and effects on the neonate . Drug Alcohol Depend. 70: S87-S101

Jones D (1990) Weaning elderly patients off psychotropic drugs in general practice: a randomised controlled trial . Health Trends 22: 164–166

Joseph A , Fu S (2003) Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease . Prog Cardiovas Dis 45: 429–441

Kabel D , Petty F (1996) A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment . Alcohol Clin Exp Res 20: 780–784

Kampman K , Pettinati H , Lynch K G , Sparkman T , O’Brien C (2003) A pilot trial of olanzapine for the treatment of cocaine dependence . Drug Alcohol Depend 70: 265–273

Kandall S R , Doberczak T M , Jantunen M , Stein J (1999) The methadonemaintained pregnancy . Clin Perinatol 26: 173–183

Kapur B , Hackman R , Selby P , Klein J , Koren G (2001) Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy . Curr Ther Res Clin Exp 62: 274–278

Keaney F , Strang J , Gossop M , Marshall E , Farrell M , Welch S , Hahn B , Gonzalez A (2001) A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide . Alcohol Alcohol 36: 426–430

Kelly C , McCreadie R (2000) Cigarette smoking and schizophrenia . Adv Psychiatr Treat 6: 327–331

Kiefer F , Jahn H , Tarnaske T , Helwig H , Briken P , Holzbach R , Kampf P , Stracke R , Baehr M , Naber D , Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study . Arch Gen Psychiatry 60: 92–99

Kinnunen T , Doherty K , Militello F , Garvey A (1996) Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement . J Consult Clin Psychol 64: 791–798

Kirchmayer U , Davoli M , Verster A (2003) Naltrexone maintenance treatment for opioid dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Kleber H , Weissman M , Rounsaville B , Wilber C , Prusoff B , Riordan C (1983) Imipramine as treatment for depression in addicts . Arch Gen Psychiatry 40: 649–653

Klee H , Morris J (1997) Amphetamine misuse: the effects of social context on injection related risk behaviour . Addict Res 5: 329–342

Kolar A , Brown B , Weddington W , Haertzen C , Michaelson B , Jaffe J (1992) Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine . Int J Addict 27: 849–868

Koob G , Mason B , De Witte P , Littlejohn J , Siggins G (2002) Potential neuroprotective effects of acamprosate . Alcohol Clin Exp Res 26: 586–592

Kosten T (1994) Buprenorphine for benzodiazepine-abusing heroin addicts . Am J Psychiatry 15: 151-151

Kosten T , O’Connor P (2003) Management of drug and alcohol withdrawal . N Engl J Med 348: 1786–1794

Kosten T , Morgan C , Falcione J , Schottenfeld R (1992) Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine . Arch Gen Psychiatry 49: 894–898

Kosten T , Markou A , Koob G (1998) Depression and stimulant dependence: neurobiology and pharmacology . J Nerv Ment Dis 186: 737–745

Kownacki R , Shadish W (1999) Does Alcoholics Anonymous work? The results from a meta-analysis of controlled experiments . Subst Use Misuse 34: 1897–1916

Kranzler H (2000) Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research . Alcohol Alcohol 35: 537–547

Kranzler H R , Van Kirk J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis . Alcohol Clin Exp Res 25: 1335–1341

Kranzler H , Burleson J , Del Boca F , Babor T , Korner P , Brown J , Bohn M (1994) Buspirone treatment of anxious alcoholics. A placebo-controlled trial . Arch Gen Psychiatry 51: 720–731

Kranzler H , Burleson J , Korner P , Del Boca F , Bohn M , Brown J , Liebowitz N (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics . Am J Psychiatry 152: 391–397

Kranzler H , Burleson J , Brown J , Babor T (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioural therapy in type B alcoholics . Alcohol Clin Exp Res 20: 1534–1541

Kranzler H , Modesto-Lowe V , Van Kirk J (2000) Naltrexone versus nefazodone for treatment of alcohol dependence: a placebo-controlled trial . Neuropsychopharmacology 22: 493–502

Krystal J , Carmer J , Krol W , Kirk G , Rosenheck R (2001) Naltrexone in the treatment of alcohol dependence . N Engl J Med 345: 1734–1771

Lader M , Morton S (1991) Benzodiazepine problems . Br J Addict 86: 823–828

Ladewig D , Knecht T , Leher P , Fendl A (1993) [Acamprosate – a stabilizing factor in long-term withdrawal of alcoholic patients] . Ther Umsch 50: 182–188

Lal B , Singh G (1976) Experiences of a methadone detoxification programme for opium addicts . Drug Alcohol Depend 1: 391–398

Lasser K , Boyd J W , Woolhandler S , Himmelstein D U , McCormick D , Bor D H (2000) Smoking and mental illness: A population-based prevalence study . JAMA 284: 2606–2610

Latt N , Jurd S , Houseman J , Wutzke S (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting . MJA 176: 530–534

Lejoyeux M , Solomon J , Ades J (1998) Benzodiazepine treatment for alcohol-dependent patients . Alcohol Alcohol 33: 563–575

Lesch O M , Walter H (1996) Subtypes of alcoholism and their role in therapy . Alcohol Alcohol 31 (Suppl 1): 63–67

Levin F , Evans S , Coomaraswammy S , Collins E , Regent N , Kleber H (1998) Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study . Am J Drug Alcohol Abuse 24: 343–360

Lima M S , de Oliveira Soares B G , Reisser A A , Farrell M (2002) Pharmacological treatment of cocaine dependence: a systematic review . Addiction 97(8): 931–949

Lima A , Lima M , Soares B , Farrell M (2003a) Carbamazepine for cocaine dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Lima M , Reisser A , Soares B , Farrell M (2003b) Antidepressants for cocaine dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Lindberg M C , Oyler R A (1990) Wernicke’s encephalopathy . Am Fam Physician 41: 1205–1209

Ling W (1978) Naltrexone: the clinical investigator’s dilemma. NIDA Res Monogr 308–314

Lintzeris N , Bell J , Bammer G , Jolley D , Rushworth L (2002a) A randomised controlled trial of buprenorphine in the ambulatory management of heroin withdrawal . Addiction 97: 1395–1404

Lintzeris N (2002b) Buprenorphine dosing regimes in the management of outpatient heroin withdrawal . Drug Alcohol Rev 21(1): 39–45

Lintzeris N , Bammer G , Rushworth L , Jolley D , Whelan G (2003) Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom triggered dose titration study . Drug Alocohol Dependence 70(3): 287–294

Liskow B , Goodwin D (1987) Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review . J Stud Alcohol 48: 356–370

Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90: 1179–1188

Littrell K , Petty R , Hilligoss N , Peabody C , Johnson C (2001) Olanzapine treatment for patients with schizophrenia and substance abuse . J Subst Abuse Treat 21: 217–221

Lucht M , Kuehn K , Armbruster J , Gaensicke M , Barnow S , Tretzel H , Freyberger H (2003) Alcohol withdrawal treatment in intoxicated versus non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam . Alcohol Alcohol 38: 168–175

Lumley J Oliver S , Waters E (1999) Interventions for promoting smoking cessation during pregnancy (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Lutiger B , Graham K , Einarson T R , Koren G (1991) Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis . Teratology 44: 405–414

Luty J , Nikolaou V , Bearn J (2003) Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 24: 363–367

Malcolm R , Myrick H , Roberts J , Wang W , Anton R F , Ballenger J C (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial . J Gen Intern Med 17(5): 349–355

Malcolm R , Anton R , Randall C , Johnston A , Brady K , Thevos A (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics . Alcohol Clin Exp Res 16: 1007–1013

Malcolm R , Roberts J , Wang W , Myrick H , Anton R (2000) Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification . Alcohol 22: 159–164

Malec E , Malec T , Gagne M , Dongier M (1996) Buspirone in the treatment of alcohol dependence: a placebo-controlled trial . Alcohol Clin Exp Res 20: 307–312

Mann K , Lehert P , Morgan M Y (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis . Alcohol Clin Exp Res 28: 51–63

Mant A , Walsh R (1997) Reducing benzodiazepine use . Drug Alcohol Rev 16: 77–84

Marcus P , Snyder R (1995) Reduction of comorbid substance abuse with clozapine . Am J Psychiatry 152: 959-959

Margolin A , Kosten T , Avants S , Wilkins J , Ling W , Beckson M , Arndt I , Cornish J , Ascher J , Li S-H , Bridge P (1995) A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients . Drug Alcohol Depend 40: 125–131

Marsch L A (1998) The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a metaanalysis . Addiction 93: 515–532

Martin J , Calfas K , Patten C , Polarek M , Hofstetter C , Noto J , Beach D (1997) Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of Project SCRAP-Tobacco . J Consult Clin Psychol 65: 190–194

Martin P R , Adinoff B , Lane E , Stapleton J M , Bone G A , Weingartner H , Linnoila M , Eckardt M J (1995) Fluvoxamine treatment of alcoholic amnestic disorder . Eur Neuropsychopharmacol 5: 27–33

Mason B (2003) Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment . Eur Neuropsychopharmacol 13: 469–475

Mason B , Kocsis J , Ritvo E , Cutler R (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependencest ratified on the presence or absence of major depression . JAMA 275: 761–767

Mattick R , Breen C , Kimber J , Davoli M (2003a) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Mattick R , Kimber J , Breen C , Davoli M (2003b) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Mayo-Smith M (1997) Pharmacological management of alcohol withdrawal . JAMA 278: 144–151

McBride W J , Li T K (1998) Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents . Crit Rev Neurobiol 12: 339–369

McBride A J , Sullivan JT , Blewett A (1997) Amphetamine prescribing as a harm reduction measure: a preliminary study . Addict Res 5: 95–112

McDowell D , Levin F , Seracini A , Nunes E (2000) Venlafaxine treatment of cocaine abusers with depressive disorders . Am J Drug Alcohol Abuse 26: 25–31

McEvoy J , Freudenreich O , McGee M , VanderZwaag E L , Rose J (1995) Clozapine decreases smoking in patients with chronic schizophrenia . Biol Psychiatry 37: 550–552

McEvoy J , Freudenreich O , Wilson W (1999) Smoking and therapeutic response to clozapine in patients with schizophrenia . Biol Psychiatry 46: 125–129

McGrath P , Nunes E , Stewart J , Goldman D , Agosti V , Ocepek-Welikson K , Quitkin F (1996) Imipramine treatment of alcoholics with primary depression . Arch Gen Psychiatry 53: 232–240

McInnes G (1987) Chlormethiazole and alcohol: a lethal cocktail . BMJ 294: 592-592

McLellan A , Amdt I , Metzger D , Woody G , O’Brien C (1993) The effects of psychosocial services in substance abuse treatment . JAMA 269: 1953–1959

McRobbie H , Hajek P (2001) Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals . Addiction 96: 1547–1551

Merrill J , Tetlow V A (1998) Prescribing for amphetamine users: evaluation of a dexamphetamine substitution programme. In: Beyond Oral Methadone: Expanded Pharmacotherapies for the Treatment of Drug Dependence. New York Academy of Medicine, New York

Miller W R , Brown J M , Simpson T L , Handmaker N S , Bien T H , Luckie LF , Montgomery H A , Hester R K , Tonigan J S (1995) What works? A methodological analysis of the alcohol treatment outcome literature. In Hester R K , Miller W R (eds), Handbook of alcoholism treatment approaches: effective alternatives, pp. 12–44. Allyn & Bacon, Boston, MA

Miller W R , Wilbourne P L (2002) Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders . Addiction 97: 265–277

Miotto K , McCann M , Basch J , Rawson R , Ling W (2002) Naltrexone and dysphoria: fact or myth? Am J Addict 11: 151–160

Montgomery S A , Cowen P J , Deakin W , Freeling P , Hallstrom C , Katona C , King D , Leonard B , Levine S , Phanjoo A , Peet M , Thompson C (1993) Guidelines for the treating depressive illness with antidepressants. A statement from the British Association for Psychopharmacology . J Psychopharmacol 7: 19–23 .

Monti P M , Rohsenow D J , Rubonis A V , Niaura R S , Sirota A D , Colby S M , Goddard P , Abrams D B (1993) Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation . J Consult Clin Psychol 61: 1011–1019

Monti P et al. (2001) Research: naltrexone and coping-skills training can limit relapse . Alcohol Drug Abuse Week 13: 3–4

Morgan M Y (1995) The management of alcohol withdrawal using chlormethiazole . Alcohol Alcohol 30: 771–774

Morgenstern J , Longabaugh R (2000) Cognitive-behavioural treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action . Addiction 95: 1475–1490

Morton S , Lader M (1995) Buspirone treatment as an aid to benzodiazepine withdrawal . J Psychopharmacol 9: 331–335

Moyer A , Finney J W , Swearingen C E , Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations . Addiction 97: 279–292

Mrazek M , Menges C , Steffes J , Thelen B , Erkwoh R (1999) [Therapeutic experiences with alcohol-related Korsakoff syndrome] . Nervenarzt 70: 790–794

Murphy S , Tyrer P (1991) A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence . Br J Psychiatry 158: 511–516

Murray R P , Bailey W C , Daniels K , Bjornson W M , Kurnow K , Connett J E , Nides M A , Kiley J P (1996) Safety of nicotine polacrilex gum used by 3094 participants in the Lung Health Study. Lung Health Study Research Group . Chest 109: 438–445

Naranjo C , Sellers E , Sullivan J , Woodley D , Kadlec K , Sykora K (1987) The serotonin uptake inhibitor citalopram attenuates ethanol intake . Clin Pharmacol Ther 41: 266–274

Naranjo C , Kadlec K , Sanhueza P , Woodley-Remus D , Sellers E (1990) Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers . Clin Pharmacol Ther 47: 490–498

Naranjo C , Bremner K , Lanctot K (1995) Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems . Addiction 90: 87–99

National Institute for Clinical Excellence (2002) Nicotine replacement therapy [NRT] and bupropion for smoking cessation. London Technology Appraisal Guidance no. 38, London

Nelson C , Rehm J , Ustun T , Grant B , Chatterji S (1999) Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study . Addiction 94: 583–588

Noordsy D , O’Keefe C , Mueser K , Xie H (2001) Six-month outcomes for patients who switched to Olanzapine treatment . Psychiatr Serv 52: 501–507

Nunes E , Quitkin F (1997) Treatment of depression in drug-dependent patients: effects on mood and drug use . In: Drug-dependent individuals with comorbid mental disorders. NIDA Research Monograph, number 172: 61–84

Nunes E , Levin F (2004) Treatment of depression in patients with alcohol or other drug dependence: a Meta-analysis . JAMA 291: 1887–1896

Nunes E , McGrath P , Quitkin F , Stewart J , Harrison W , Tricamo E , Ocepek-Welikson K (1993) Imipramine treatment of alcoholism with comorbid depression . Am J Psychiatry 150: 1248-1248

Nunes E , McGrath P , Quitkin F , Ocepek-Welikson K , Stewart J , Koenig T , Wager S , Klein D (1995) Imipramine treatment of cocaine abuse: possible boundaries of efficacy . Drug Alcohol Depend 39: 185–195

Nunes E , Quitkin F , Donovan S , Deliyannides D , Ocepek-Welikson K , Koenig T , Brady R , McGrath P , Woody G (1998) Imipramine treatment of opiate-dependent patients with depressive disorders . Arch Gen Psychiatry 55: 153–160

Nutt D J (2003) Death and dependence: current controversies over the selective serotonin reuptake inhibitors . J Psychopharmacol 17: 355–364

O’Carroll R E , Moffoot A P , Ebmeier K P , Goodwin G M (1994) Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakoff syndrome . Psychopharmacology (Berl) 116: 85–88

O’Farrell T J , Fals-Stewart W (2001) Family involved alcoholism treatment. An update . Recent Dev Alcohol 15: 329–356

O’Malley S S , Jaffe A J , Chang G , Schottenfeld R S , Meyer R E , Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study . Arch Gen Psychiatry 49: 881–887

O’Malley S , Jaffe A , Chang G , Rode S , Schottenfeld R , Meyer R , Rounsaville B (1996) Six-month follow-up of naltrexone andpsychotherapy for alcohol dependence . Arch Gen Psychiatry 53: 217–231

O’Malley S , Krishnan-Sarin S , Conor F , O’Connor P (2000) Naltrexoneinduced nausea in patients treated for alcohol dependence: clinicalpredictors and evidence for opioid-mediated effects . J Clin Psycho-pharmacol 20: 69–76

O’Malley S , Rounsaville B , Farren C , Namkoong K , Wu R , Robinson J , O’Connor P (2003) Initial and maintenance naltrexone treatment for alcohol dependence using primary care versus specialty care . Arch Intern Med 163: 1695–1703

Oslin D , Pettinati H , Volpicelli J , Wolf A , Kampman K , O’Brien C (1999) The effects of naltrexone on alcohol and cocaine use in dually addicted patients . J Subst Abuse Treat 16: 163–167

Otto M , Pollack M , Sachs G , Reiter S , Meltzer B , Rosenbaum J (1993) Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioural therapy for patients with panic disorder . Am J Psychiatry 50: 1485–1490

Oude-Voshaar R , Gorgels W , Mol A , VanBalkom A , Van de Lisdonk E , Breteler M , Van den Hoogen H , Zitman F (2003) Tapering off long-term benzodiazepine use with or without group cognitive-behaviouraltherapy: three condition, randomised controlled trial . Br J Psychiatry 182: 498–504

Pates R , Coombes N , Ford N (1996) A pilot programme in prescribing dexamphetamine for amphetamine users (part 1) . J Subst Misuse 1: 80–84

Patten C , Drews A , Myers M , Martin J , Wolter T (2002) Effect of depressive symptoms on smoking abstinence and treatment adherence among smokers with a history of alcohol dependence . Psychol Addict Behav 16: 135–142

Perneger T V , Giner F , del Rio M , Mino A (1998) Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments . BMJ 317: 13–18

Peterson P L , Lowe J B (1992) Preventing fetal alcohol exposure: a cognitive behavioral approach . Int J Addict 27: 613–626

Petrakis I , Carroll K , Nich C , Gordon L , Kosten T , Rounsaville B (1998) Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts . Drug Alcohol Depend 50: 221–226

Petrakis I , Carroll K , Nich C , Gordon L , McCance-Katz E , Frankforter T , Rounsaville B (2000) Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts . Addiction 95: 219–228

Petrakis I , O’Malley S , Rounsaville B , Poling J , McHugh-Strong C , Krystal J (2003) Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia . Psychopharmacology 00: 1–13

Petrovic M , Pevernagie D , Dan Den N , Mariman A , Miachaelsen W , Afshcrift M (1999) A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality . Int J Geriatr Psychiatry 14: 754–760

Pettinati H , Volpicelli J , Kranzler H , Luck G , Rukstanlis M , Cnaan A (2000) Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype . Alcohol Clin Exp Res 24: 1041–1049

Pettinati H , Volpicelli J , Luck G , Kranzler H , Rukstalis M , Cnaan A (2001) Double-blind clinical trial of sertraline treatment for alcohol dependence . J Clin Psychopharmacol 21: 143–153

Poikolainen K (1999) Effectiveness of brief interventions to reduce alcohol intake in primary health care populations: a meta-analysis . Prev Med 28: 503–509

Poldrugo F (1997) Acamprosate treatment in a long-term community-based alcohol rehabilitation programme . Addiction 92: 1537–1546

Pomerleau C , Brouwer R , Pomerleau O (2001) Emergence of depression during early abstinence in depressed and non-depressed women smokers . Addict Dis 20: 73–80

Posternak M A , Mueller T I (2001) Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence . Am J Addict 10: 48–68

Powell B , Campbell J , Landon J , Liskow B , Thomas H , Nickel E , Dale T , Penick E , Samuelson S , Lacoursiere R (1995) A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders . Alcohol Clin Exp Res 19: 462–468

Project MATCH Research Group (1998) Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group . J Stud Alcohol 59: 631–639

Raistrick D (2001) Alcohol withdrawal and detoxification. In Heather N , Peters T , Stockwell T (eds), International handbook of alcohol dependence and problems, pp. 523–539. John Wiley & Sons Ltd, Chichester, UK

Randall C L , Thomas S E , Thevos A K (2000) Gender comparison in alcoholics with concurrent social phobia: implications for alcoholism treatment . Am J Addict 9: 202–215

Randall C L , Thomas S , Thevos A K (2001a) Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments . Alcohol Clin Exp Res 25: 210–220

Randall C L , Johnson M R , Thevos A K , Sonne S C , Thomas S E , Willard S L , Brady K T , Davidson J R (2001b) Paroxetine for social anxiety and alcohol use in dual-diagnosed patients . Depress Anxiety 14: 255–262

Rathlev N K , D’Onofrio G , Fish S S , Harrison P M , Bernstein E , Hossack R W , Pickens L (1994) The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures . Ann Emerg Med 23: 513–518

Rawson R A , Mann A J , Tennant F S Jr , Clabough D (1983) Efficacy of psychotherapeutic counselling during 21-day ambulatory heroin detoxification . NIDA Res Monogr 43: 310–314

Rawson R A , Huber A , McCann M , Shoptaw S , Farabee D , Reiber C , Ling W (2002) A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence . Arch Gen Psychiatry 59: 817–824

Regier D A , Farmer M E , Rae D S , Locke B Z , Keith S J , Judd L L , Goodwin F K (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study . JAMA 264: 2511–2518

Reuler J B , Girard D E , Cooney T G (1985) Current concepts. Wernicke’s encephalopathy . N Engl J Med 312: 1035–1039

Reuster T , Buechler J , Winiecki P , Oehler J (2003) Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff’s syndrome . Neuropsycho-pharmacology 28: 974–978

Richter K P , McCool R M , Okuyemi K S , Mayo M S , Ahluwalia J S (2002) Patients’ views on smoking cessation and tobacco harm reduction during drug treatment . Nicotine Tob Res 4 (Suppl 2): S175–S182

Rickels K , Case W , Schweizer E , Garcia-Espagna F , Fridman R (1990) Benzodiazepine dependence: management of discontinuation . Psychopharmacol Bull 26: 63–68

Rickels K , Schweizer E , Garcia E , Case G , DeMartinis N , Greenblatt D (1999) Trazodone and valporate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome . Psychopharmacology 141: 1–5

Ries P , Roy-Byrne P , Ward N , Neppe V , Cullison S (1989) Carbamazepine treatment for benzodiazepine withdrawal . Am J Psychiatry 146: 536–537

Rohsenow D J , Monti P M , Rubonis A V , Gulliver S B , Colby S M , Binkoff J A , Abrams D B (2001) Cue exposure with coping skills training and communication skills training for alcohol dependence: 6-and 12-month outcomes . Addiction 96: 1161–1174

Romberger D , Grant K (2004) Alcohol consumption and smoking status: the role of smoking cessation . Biomed Pharmacother 58: 77–83

Roozen H , Boulogne J , Tulder M , van den Brink W , De Jong CA , Kerkhof AJ (2004) A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction . Drug Alcohol Depend 74: 1–13

Ross J , Darke S (2000) The nature of benzodiazepine dependence among heroin users in Sydney, Australia . Addiction 95: 1785–1793

Roy-Byrne P , Pages K , Russo J , Jaffe C , Blume A , Kingsley E , Cowley D , Ries R (2000) Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial . J Clin Psychopharmacol 20: 129–136

Roy A (1998) Placebo-controlled study of sertraline in depressed recently abstinent alcoholics . Biol Psychiatry 44: 633–637

Royal College of Physicians (2001) Alcohol – can the NHS afford it? Royal College of Physicians, London

Rubio G , Jimenez-Arriero M , Ponce G , Palomo T (2001) Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment . Alcohol Alcohol 36: 419–425

Rustembegovic A , Kundurovic Z , Sapcanin A , Sofic E (2003) A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke–Korsakoff syndrome . Med Arh 57: 149–150

Sahin H A , Gurvit I H , Bilgic B , Hanagasi H A , Emre M (2002) Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff’s disease . Clin Neuropharmacol 25: 16–20

Saitz R , Mayo-Smith M F , Roberts M S , Redmond H A , Bernard D R , Calkins D R (1994) Individualized treatment for alcohol withdrawal . A randomized double-blind controlled trial. JAMA 272: 519–523

San L , Cami J , Fernandez T , Olle J M , Peri J M , Torrens M (1992) Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects . Br J Addict 87: 55–62

Sass H , Soyka M , Mann K , Zieglgansberger M (1996) Relapse prevention by acamprosate . Arch Gen Psychiatry 53: 673–680

Saxon A , McGuffin R , Dale Walker R (1997) An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol and drug-dependent inpatients . J Subst Abuse Treat 14: 333–337

Schmitz J , Averill P , Stotts A , Moeller F , Rhoades H , Grabowski J (2001) Fluoxetine treatment of cocaine-dependent patients with major depressive disorder . Drug Alcohol Depend 63: 207–214

Schuckit M A , Tipp J E , Reich T , Hesselbrock V M , Bucholz K K (1995) The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects . Addiction 90: 1335–1347

Schweizer E , Rickels K (1998) Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management . Acta Psychiatr Scand 98: 95–101

Schweizer E , Rickels K , Case W , Greenblatt D (1991) Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy . Effects on withdrawal severity and outcome. Arch Gen Psychiatry 8: 448–452

Scott J , Gilvarry E , Farrell M (1998) Managing anxiety and depression in alcohol and drug dependence . Addict Behav 23: 919–931

Seivewright N (1998) Theory and practice in managing benzodiazepine dependence and abuse . J Subst Misuse 3: 170–177

Seivewright N (2000) More than methadone? The case for other substitute drugs. Community treatment of drug misuse: more than methadone, pp. 49–81. Cambridge University Press, Cambridge, UK

Seivewright N , Donmall M , Daly C (1993) Benzodiazepines in illicit drug scene – the UK picture and some treatment dilemmas . Int J Drug Policy 4: 42–48

Sellers E M , Naranjo C A , Harrison M , Devenyi P , Roach C , Sykora K (1983) Diazepam loading: simplified treatment of alcohol withdrawal . Clin Pharmacol Ther 34: 822–826

Senay E C , Dorus W , Goldberg F , Thornton W (1977) Withdrawal from methadone maintenance . Rate of withdrawal and expectation. Arch Gen Psychiatry 34: 361–367

Senay E C , Dorus W , Showalter C V (1981) Short-term detoxification with methadone . Ann NY Acad Sci 362: 203–216

Sgouros X , Baines M , Bloor R N , McAuley R , Ogundipe L O , Willmott S (2004) Evaluation of a clinical screening instrument to identify states of thiamine deficiency in inpatients with severe alcohol dependencesyndrome . Alcohol Alcohol 39(3): 227–232

Shand F , Gates J , Fawcett J , Mattick RP (2003) The treatment of alcohol problems: a review of the evidence. National Drug and Alcohol Research Centre. Department of Health and Ageing, Australia

Shearer J , Wodak A , Mattick R P , van B I , Lewis J , Hall W , Dolan K (2001) Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence . Addiction 96: 1289–1296

Shearer J , Wodak A , van B I , Mattick R P , Lewis J (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence . Addiction 98: 1137–1141

Shekelle P G , Woolf S H , Eccles M , Grimshaw J (1999) Clinical guidelines: developing guidelines . BMJ 318: 593–596

Silagy C , Lancaster T , Stead L , Mant D , Fowler G (2003) Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Siris S G (1990) Pharmacological treatment of substance-abusing schizophrenic patients . Schizophr Bull 16: 111–122

Slattery J , Chick J , Cochrane M , Godfrey C , Kohli H , Macpherson K , Parott S , Quinn S , Single A , Tochel C , Watson H (2003) Prevention of relapse in alcohol dependence. Health Technology Assessment Report 3. Health Technology Board for Scotland, Glasgow

Smelson D , Losonczy M , Davis C , Kaune M , Williams J , Ziedonis D (2002) Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence . Can J Psychiatry 47: 671–675

Smith N (2002) A review of the published literature into cannabis withdrawal symptoms in human users . Addiction 97: 621–632

Soares B , Limas M , Reisser A , Farrell M (2003) Dopamine agonists for cocaine dependence (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Sokol R J , Delaney-Black V , Nordstrom B (2003) Fetal alcohol spectrum disorder . JAMA 290: 2996–2999

Sonne S C , Brady K T (2002) Bipolar disorder and alcoholism . Alcohol Res Health 26: 103–108

Sorensen J L , Hargreaves W A , Weinberg J A (1982) Withdrawal from heroin in three or six weeks . Comparison of methadyl acetate and methadone. Arch Gen Psychiatry 39: 167–171

Soyka M , Sass H (1994) Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism – preliminary data . Alcohol Alcohol 2: 531–536

Srisurapanont M , Jarusuraisin N (2003a) Opioid antagonists for alcohol dependence. (Cochrane Review) In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Srisurapanont M , Jarusuraisin N , Kittirattanapaiboon P (2003b) Treatment for amphetamine dependence and abuse (Cochrane Review). In: The Cochrane Library. John Wiley & Sons, Ltd, Chichester

Stitzer M , Bigelow G , Liebson I , Hawthorne J (1992) Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abusetreatment intervention . J Appl Behav Anal 15: 493–503

Strang J , Gossop M (1990) Comparison of linear versus inverseexponential methadone reduction curves in the detoxification of opiate addicts . Addict Behav 15: 541–547

Strang J , Marsden J , Cummins M , Farrell M , Finch E , Gossop M , Stewart D , Welch S (2000) Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome . Addiction 95: 1631–1645

Stratton K , Howe C , Battaglia F (1996) Fetal alcohol syndrome: diagnosis, epidemiology, prevention and treatment. National Academy Press, Washington DC

Streeton C , Whelan G (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials . Alcohol Alcohol 36: 544–552

Swift R (1999) Drug therapy for alcohol dependence . N Engl J Med 340: 1482–1490

Tashkin D , Kanner R , Bailey W , Buist S , Anderson P , Nides M , Gonzales D , Dozier G , Patel M K , Jamerson B (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial . Lancet 357: 1571–1575

Taylor D J (1999) Alcohol Consumption in Pregnancy (9). Royal College of Obstetricians and Gynecologists. http://www.rcog.org.uk/

Tennant F S Jr , Russell B A , Casas S K , Bleich R N (1975) Heroin detoxification. A comparison of propoxyphene and methadone . JAMA 232: 1019–1022

Thomas J D , Riley E P (1998) Fetal Alcohol Syndome . Does alcohol withdrawal play a role? Alcohol Res Health 22: 47–53

Thomson A D (2000) Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke–Korsakoff syndrome . Alcohol Alcohol Suppl 35 (Suppl 1): 2–7

Thomson A , Cook C , Touquet R , Henry J (2002) The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the accident and emergency department . Alcohol Alcohol 37: 513–521

Thorsteinsson H , Gillin J , Patten C , Golshan S , Sutton L , Drummond S , Clark C , Kelsoe J , Rapaport M (2001) The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression . Neuropsychopharmacology 24: 350–358

Tiihonen J , Ryynanen O-P , Kauhanen J , Hakola H , Salaspuro M (1996) Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study . Pharmacopsychiatry 29: 27–29

Titievsky J , Seco G , Barranco M , Kyle E (1982) Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study . J Clin Psychiatry 43: 454–456

Tober G , Strang J (2003) Methadone matters: evolving practice of community methadone treatment of opiate addiction. Taylor & Francis, New York

Tollefson G , Montague-Clouse J , Tollefson S (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone) . J Clin Psychopharmacol 12: 19–26

Tonstad S , Farsang C , Klaene G , Lewis K , Manolis A , Perruchoud A P , Silagy C , Van Spiegel P I , Astbury C , Hider A , Sweet R (2003) Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study . Eur Heart J 24: 946–955

Tsuang J , Eckman T , Shaner A , Marder S (1999) Clozapine for substanceabusing schizophrenic patients . Am J Psychiatry 156: 1119–1120

Turnbull P J , McSweney T , Webster R , Edmunds M , Hough M (2000) Drug treatment and testing orders: final evaluation report. Home Office Research Study 212. Home Office, London

Tyrer P , Rutherford D , Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol . Lancet 1: 520–522

Tyrer P , Owen R , Dawling (1983) Gradual withdrawal of diazepam after long-term therapy . Lancet 1: 1402–1406

Tyrer P , Ferguson B , Hallstrom C , Michie M , Tyrer S , Cooper S , Caplan R , Barczak P (1996) A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms . Br J Psychiatry 168: 457–461

Udelman H , Udelman D (1990) Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy . J Clin Psychiatry 51: 46–50

UKATT Research Team (2001) United Kingdom Alcohol Treatment Trial (UKATT): hypotheses, design and methods . Alcohol Alcohol 36: 11–21

Ulm R , Volpicelli J , Volpicelli L (1995) Opiates and alcohol self-administration in animals . J Clin Psychiatry 56: 5–14

United States Department of Health and Human Services (2000) Reducing tobacco use. A report of the Surgeon General. Executive summary. MMWR Recommunication Rep. United States Department of Health & Human Services 49: 1–27

Van den Brink W , van Ree J (2003) Pharmacological treatments for heroin and cocaine addiction . Eur Neuropsychopharmacol 13: 476–487

Van den Brink W , Hendriks V , Blanken P , Koeter M , van Zwieten B , van Ree J (2003) Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials . BMJ 327–310

Van Valkenburg C , Akiskal H (1999) Which patients presenting with clinical anxiety will abuse benzodiazepines? Hum Psychopharmacol 14: S45-S51

Verheul R , van den B W , Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol . Alcohol Alcohol 34: 197–222

Verheul R , Lehert P , Geerlings P J , Koeter M W , van den Brink W (2004) Predictors of acamprosate efficacy: results from a pooled analysis of 7 European trials including 1485 alcohol-dependent patients. Psycho-pharmacology, in press

Victor M V , Adams R C , Collins G H (1989) The Wernicke-Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition. FA Davis., Philadelphia, PA

Vito G F , Tewksbury R A (1998) The impact of treatment: The Jefferson county (Kentucky) drug court program . Fed Probat 62: 46–51

Volpicelli J R , Clay K L , Watson N T , O’Brien C P (1995) Naltrexone in the treatment of alcoholism: predicting response to naltrexone . J Clin Psychiatry 56 (Suppl 7): 39–44

Volpicelli J , Rhines K , Volpicelli L , Alterman A , O’Brien C (1997) Naltrexone and alcohol dependence . Arch Gen Psychiatry 54: 737–742

Vorma H , Naukkarinen H , Sarna S , Kuoppasalmi K (2002) Treatment of outpatients with complicated benzodiazepine dependence: comparison of two approaches . Addiction 97: 851–859

Walsh D C , Hingson R W , Merrigan D M , Levenson S M , Cupples L A , Heeren T , Coffman G A , Becker C A , Barker T A , Hamilton S K (1991) A randomized trial of treatment options for alcohol-abusing workers . N Engl J Med 325: 775–782

Walters G D (2000) Behavioural self-control training for problem drinkers: a meta-analysis of randomized control studies . Behav Ther 31: 135–149

Wang E C (1999) Methadone treatment during pregnancy . J Obstet Gynecol Neonatal Nurs 28: 615–622

Weddington W , Brown B , Haertzen C , Hess J , Mahaffey J , Kolar A , Jaffe J (1991) Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence . Am J Drug Alcohol Abuse 17: 137–152

Weiner E , Ball M , Summefelt A , Gold J , Buchanan R (2001) Effects ofsustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia . Am J Psychiatry 158: 635–637

Weiss R D , Greenfield S F , Najavits L M , Soto J A , Wyner D , Tohen M , Griffin M L (1998) Medication compliance among patients with bipolar disorder and substance use disorder . J Clin Psychiatry 59: 172–174